Koronis Pharmaceuticals

About:

Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism.

Website: http://www.koronispharma.com

Top Investors: Asset Management Ventures (AMV), Pacific Horizon Ventures

Description:

Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism. It is a privately held biotechnology company developing antiviral therapeutics based on a novel mechanism, Viral Decay Accelerationâ„¢ (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV. It was founded in 1998 and is based in Seattle, Washington.